Ionis Pharmaceuticals Inc (IONS): Capital Expenditures
$51.44M
Year ended 2025-12-31
$64.41M
Trailing 12 months to 2026-06-30
+48.5%
3-year compound annual growth
+7.9%
5-year compound annual growth
+20.9%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $51.44M | +13.6% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $45.28M | +90.2% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $23.80M | +51.4% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $15.72M | +31.5% | 2025-02-19, From 2022-01-01 |
| 2021-12-31 | $11.96M | -66.0% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $35.12M | +13.6% | 2023-02-22, From 2020-01-01 |
| 2019-12-31 | $30.91M | +127.1% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $13.61M | -60.9% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $34.76M | +389.2% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $7.11M | -7.6% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $7.69M | +2.3% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $7.52M | +384.4% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $1.55M | +4.9% | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | $1.48M | -85.5% | 2015-03-02, From 2012-01-01 |
| 2011-12-31 | $10.20M | -22.9% | 2014-03-03, From 2011-01-01 |
| 2010-12-31 | $13.24M | -1.3% | 2013-02-28, From 2010-01-01 |
| 2009-12-31 | $13.41M | -1.8% | 2012-02-29, From 2009-01-01 |
| 2008-12-31 | $13.66M | n/a | 2011-03-01, From 2008-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $51.44M | +13.6% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $467.0K | -68.1% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $13.84M | -14.8% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $310.0K | -73.1% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $4.69M | +796.7% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $22.67M | -84.0% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $11.18M | +35.9% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.74M | +5.3% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $211.0K | -90.3% |
Compare IONS, MDGL, ANIP, HRMY side by side · Screen every company in Pharmaceutical Preparations ↗